At NEUROCENTRIA, we are dedicated to bringing innovative medicines to patients with cognitive impairment disorders. We are committed to partnerships and collaborations to expand access to our future products and to complement our portfolio of product candidates.
As part of our strategy, we selectively pursue strategic development or commercialization collaborations to advance and maximize the potential of our pipeline. We welcome the opportunity to learn more about how we can work together. To further explore partnering opportunities with NEUROCENTRIA, please contact us below.
At NEUROCENTRIA, we are interested in accredited and institutional investors who recognize the substantial medical need related to diseases that cause cognitive impairment. We foresee substantial opportunity related to each of the indications we’re developing clinically, as well as a broader pipeline based on our fundamental new science. To further explore investment opportunities with NEUROCENTRIA, please contact us.
800 S Broadway
Walnut Creek, CA 94596 USA
TEL +1 925.954.4868